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Miliary TB Disease with TB Meningitis
A form of TB that is easy to misdiagnose and is often fatal
Jamie Skreen, DO PGY3
Providence Oregon Family Medicine Residency

Discussion

Case Presentation
➢
➢

➢

HPI:
35 year old woman from Vietnam without significant medical history whom
presented to the ED for headache and fever.
➢ Headache x 2 weeks. Localized to occipital region and spans down back to
tailbone. Also fever 102F for the past month.
➢ Evaluated in the ED 10 days prior to presentation for this headache and
diagnosed with an acute viral syndrome given normal labs and head CT.
➢ A few days later, she began having blurry vision, nausea, vomiting, lethargy
and had incoherent speech. She has not had any URI symptoms, cough or
hemoptysis.
➢ Re-evaluated at an urgent care and they noted some neck stiffness and
given her symptoms and exam they sent to the emergency room for
further workup.
➢ Pt has never been exposed to TB to her knowledge, but she did grow up in
Vietnam. No prior positive TB screening testing to her knowledge.
Married, non-smoker, non-drinker, and no history of IVDU. Works in a nail
salon.
Physical Examination:
➢ VS: T:103.1F / 39.5C BP: 148/97 HR: 124 RR:16 SpO2: 96% on RA
➢ Gen: Wobbly gait, tired appearing
➢ Neck: Stiff, limited neck flexion
➢ ROE unremarkable

CXR

MRI Brain

➢

➢

Fig 1. MRI Brain w wo contrast: ”Small ringenhancing lesions in the left frontal cortex and right
frontal cortex. Differential considerations are quite
broad but includes infectious and neoplastic
etiologies. No brain edema to suggest viral
encephalitis”

Fig 2. ”Diffuse pulmonary nodularity. The
differential would include respiratory bronchiolitis,
miliary tuberculosis and other fungal infections,
hypersensitivity pneumonitis and viral infection.”
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Hospital Course
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Workup in the ED:
➢ Notable labs:
➢ CSF from LP:
➢ 258 WBC (83% PMN and 17% lymphs), 518 RBCs, protein 258 (nml =
15-60), glucose 38 (33%) (nml level 8-80 and 60-70%).
➢ Sodium 121, mild transaminitis
ID recommendations:
➢ “From LP alone, DDx includes "early" viral meningitis, vs bacterial (pyogenic
vs AFB vs other atypical pathogens such as Listeria, Brucella, syphilis) vs
Cryptococcus. Other causes such as medication induced or autoimmune
(SLE etc) are possible. “
➢ Started on CTX, vancomycin, and acyclovir
➢ Follow labs for etiology: HIV, syphilis, cryptococcus, cultures including AFB,
viral including HSV and enterovirus
➢ CXR to look for evidence of prior TB
Follow up CXR:
➢ ”Diffuse pulmonary nodularity. The differential would include respiratory
bronchiolitis, miliary tuberculosis and other fungal infections,
hypersensitivity pneumonitis and viral infection.”
After CXR, she was placed on airborne precautions and in a reverse flow room.
She also received a brain MRI:
MRI brain findings:
➢ ”Small ring-enhancing lesions in the left frontal cortex and right frontal
cortex. Differential considerations are quite broad but includes infectious
and neoplastic etiologies. No brain edema to suggest viral encephalitis”
The following day:
➢ CSF resulted as positive for TB by PCR, confirming the diagnosis.
➢Treatment was immediately started.
➢ Started isoniazid (INH) 300mg/ rifampin (RIF) 600 mg / ethambutol
(EMB) 25mg/kg / pyrazinamide (PZA) 25 mg/kg (“RIPE”)
➢ Prednisone 60 mg qd for 2 weeks followed by taper
➢ Pyridoxine 50 mg qd
➢ Discontinued ceftriaxone, vancomycin, and acyclovir
➢ Continued airborne precautions
Contacted by county health department:
➢ Even though we had a diagnosis, needed sputum for AFB smear/cx to
determine level of contagiousness. Unable to produce sputum, even
with induction.
➢ Had bronchoalveolar lavage =
➢ 3+ (moderate) Mycobacterium tuberculosis

Chest CT
➢

Fig 3. Diffuse, extensive micronodules throughout the bilateral lungs, with homogeneous
distribution. These findings are nonspecific with broad differential considerations
including, but not limited to, infectious etiologies, including disseminated tuberculosis and
fungal infection, pneumoconioses, hypersensitivity pneumonitis and sarcoidosis

➢

TB CLASSIFICATION: Tuberculosis classified according to site of disease
as pulmonary or extrapulmonary;
TREATMENT: “RIPE”: isoniazid (INH) 300mg/ rifampin (RIF) 600 mg /
ethambutol (EMB) 25mg/kg / pyrazinamide (PZA) 25 mg/kg
MILIARY TB OVERVIEW:
➢ Miliary disease is classified as both extrapulmonary & pulmonary.
➢ “Miliary” refers to the CXR appearance of millet seeds scattered
throughout the lung.
➢ Characterized by a large amount of TB bacilli, although it may
easily be missed, and is fatal if left untreated.
INCIDENCE/PREVALENCE: Fewer than 2 percent of all TB cases
demonstrate miliary disease
OUTCOMES: Mortality rate is between 15 to 30%
➢ One of the main causes for high mortality includes late detection
of disease caused by non-specific symptoms
RISK FACTORS: Most common in infants and children younger than 5
years of age and in severely immunocompromised persons.
PATHOGENESIS: Can arise as a result of progressive primary infection
vs reactivation of a latent focus with subsequent spread. TB spreads
from the pulmonary system to the lymphatic system and eventually
the blood stream, but the mechanism by which this occurs is not well
understood
ORGANS INVOLVED: Miliary TB may be detected in an individual
organ, including the brain; in several organs; or throughout the whole
body.
➢ Up to 25% of patients with miliary TB may have meningeal
involvement.
DIAGNOSIS:
➢ *Culture: Gold standard for confirming diagnosis of TB. Culture all
specimens, even if smear or NAA negative. Results in 4–14 days.
Collection methods include coughing, sputum induction,
bronchoscopy, gastric aspiration.
➢ AFB smear classification
➢ NAA/PCR testing
➢ Drug-susceptibility testing
➢ **For extra pulmonary TB: Variety of clinical specimens other than
sputum can be submitted
RADIOGRAPHIC IMAGING:
➢ CXR : Miliary pattern on the chest radiograph is often the first
clue suggestive of miliary TB. Pros: ready availability, capacity to
differentiate latent TB from active TB. Cons: low sensitivity and
specificity, not confirmatory.
➢ CT Chest: Contrast-enhanced CT scans are better for detecting
additional findings, such as intrathoracic lymphadenopathy,
calcification, and pleural lesions.
➢ MRI of the Brain: Miliary CNS TB is usually associated with TBM
and appears at MRI as multiple tiny, hyperintense T2 foci that
homogeneously enhance on contrast enhanced T1-weighted
images. The MRI is particularly helpful in identifying and
delineating the extent of tuberculomas and cold abscesses and
monitoring the response to treatment.
DIFFERENTIAL DIAGNOSIS OF MILIARY TB PATTERN ON CXR:
➢ Miliary tuberculosis (TB), histoplasmosis, sarcoidosis,
pneumoconiosis, bronchoalveolar carcinoma, pulmonary siderosis,
and hematogenous metastases from primary cancers of thyroid,
kidney, trophoblast, and some of the sarcomas.

Conclusion
➢ TB meningitis is a rare and dangerous entity that can be easily missed
unless there is a high index of suspicion
➢ Early diagnosis and treatment is key to prevent mortality in these
patients
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